Peer-reviewedCC BYJAAD case reports
Clinical improvement of necrobiosis lipoidica with topical ruxolitinib.
- 1College of Medicine, Northeast Ohio Medical University, Rootstown, Ohio.
- 2Dermatology Service, Department of Veterans Affairs Louis Stokes Medical Center, Cleveland, Ohio.
- 3Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland, Ohio.
Related
- Extensive vulvar and perianal langerhans cell histiocytosis with clinical improvement during low-dose thalidomide and topical therapy: a case report
- Facial discoid dermatosis successfully treated with topical ruxolitinib: A case report
- Efficacy and Clinical Predictors of Topical NSAIDs as Bridging Therapy for Diabetic Macular Edema: A Systematic Review and Meta-Analysis
- Topical oxybutynin antiperspirant for axillary hyperhidrosis: a phase IIb PROBE design clinical trial (TODAY trial) Antitranspirante tópico de oxibutinina para hiperidrose axilar: um ensaio clínico de fase IIb com desenho PROBE (estudo TODAY)
- Vehicle Optimization of Topical Clobetasol Propionate in Disseminated Granuloma Annulare: Clinical Insights From Two Cases
BibTeX
@article{guy2026clinical,
title = {{Clinical improvement of necrobiosis lipoidica with topical ruxolitinib.}},
author = {Madeline Guy and Dennis Vidmar and Janet Wieselthier and Elma Baron and Elaine Kunzler},
journal = {JAAD case reports},
year = {2026},
month = sep,
doi = {10.1016/j.jdcr.2026.08.055},
url = {https://europepmc.org/article/MED/42903902},
note = {CC BY},
}
RIS
TY - JOUR
TI - Clinical improvement of necrobiosis lipoidica with topical ruxolitinib.
AU - Madeline Guy
AU - Dennis Vidmar
AU - Janet Wieselthier
AU - Elma Baron
AU - Elaine Kunzler
PY - 2026
DA - 2026/09/08
JO - JAAD case reports
DO - 10.1016/j.jdcr.2026.08.055
UR - https://europepmc.org/article/MED/42903902
SN - 2352-5126
ER -